| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026052 |
| Receipt No. | R000029305 |
| Scientific Title | Clinical study of mixed formulation with corticosteroid and moisturizer for asteatotic eczema |
| Date of disclosure of the study information | 2017/03/01 |
| Last modified on | 2019/10/23 (Ver. 6) |
| Basic information | ||
| Public title | Clinical study of mixed formulation with corticosteroid and moisturizer for asteatotic eczema | |
| Acronym | Clinical study of mixed formulation with corticosteroid and moisturizer for asteatotic eczema | |
| Scientific Title | Clinical study of mixed formulation with corticosteroid and moisturizer for asteatotic eczema | |
| Scientific Title:Acronym | Clinical study of mixed formulation with corticosteroid and moisturizer for asteatotic eczema | |
| Region |
|
|
| Condition | ||
| Condition | asteatotic eczema | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | comparative testing of Steroid ointment and steroid ointment+moisturizer. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | disease severity after application for 2weeks. |
| Key secondary outcomes | itching score, skin surface hydration, sweating, texture of skin |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | steroid ointment and steroid containing moisturizer | |
| Interventions/Control_2 | 7days and 14 days | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Older than 20yo.
agree to participate in this trial. person with asteatotic eczema distributed symmetrically. |
|||
| Key exclusion criteria | Person with allergic dermatitis other than asteatotic eczema.
Person with bacterial skin infection. Sever atopic dermatitis patient. Person who has hypersensitivity for steroid or steroid containing moisturizer Person who enrolled in other clinical trial within a month. Person who was disqualified by principal clinician. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Department of dermatology, Kawasaki Medical School | ||||||
| Division name | Dermatology | ||||||
| Zip code | 701-0192 | ||||||
| Address | 086-462-1111 | ||||||
| TEL | 086-462-1111 | ||||||
| ymaoyama@med.kawasaki-m.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Department of dermatology, Kawasaki Medical School, 577 Matsushima Kurashiki city, Okayama Japan | ||||||
| Division name | Dermatology | ||||||
| Zip code | 701-0192 | ||||||
| Address | 086-462-1111 | ||||||
| TEL | 086-462-1111 | ||||||
| Homepage URL | |||||||
| kmsrec@med.kawasaki-m.ac.jp | |||||||
| Sponsor | |
| Institute | Department of dermatology, Kawasaki Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kawasaki Medical School |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kawasaki Medical School |
| Address | 577 Matsushima Kurashiki Japan |
| Tel | 086-462-1111 |
| kmsrec@med.kawasaki-m.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029305 |